The SARS-CoV-2 infection in the pediatric oncology population: the definitive comprehensive report of Infectious Diseases Working Group (IDWG) of AIEOP.
Daniele ZamaAndrea ZanaroliAgnese CorbelliAndrea Lo VecchioMargherita Del BeneAntonella ColombiniFrancesca CompagnoAngelica BaroneIlaria FontaniliMaria Rosaria D'AmicoMaria Rosaria PapaMaria Grazia PetrisElisabetta CaloreShana MontaltoLinda MeneghelloLetizia BresciaRosamaria MuraMilena La SpinaPaola MuggeoSimona RinieriCristina MeazzaKatia PerruccioMonica CelliniManuela SpadeaFederico MercoliniValeria PetroniRaffaella De SantisElena SonciniMassimo ProvenziNagua GiuriciOttavio ZiinoGloria TridelloSimone CesaroPublished in: The Journal of infectious diseases (2023)
SARS-CoV-2 infection presented a self-limiting, benign course in the Italian pediatric onco-hematology population during the pandemic and its main consequence has been the discontinuation of cancer-directed therapies. The rate of asymptomatic patients who stopped chemotherapy reduced over the years, suggesting that the continuation of chemotherapy is a feasible option.